# References

> Aesthetic Peptide Research Review: references — Aesthetic Peptide Research Review reading list: skin penetration, GHK and hair, Melanotan II trials and clinical reports, and GLOW ingredient reviews.

The full reading list includes human trials, isolated-tissue experiments, animal and cell work, clinical reports and reviews.

## Skin penetration and GHK

The [isolated-skin copper study](https://pmc.ncbi.nlm.nih.gov/articles/PMC3016279/) supplies the starting point for this site. The [topical GHK review](https://pmc.ncbi.nlm.nih.gov/articles/PMC11830136/) develops the delivery problem. The [human hair-count trial](https://pmc.ncbi.nlm.nih.gov/articles/PMC4969472/) tested GHK with another ingredient, while the [gene-expression review](https://pmc.ncbi.nlm.nih.gov/articles/PMC6073405/) ranges much further into laboratory findings. The [skin-regeneration review](https://pmc.ncbi.nlm.nih.gov/articles/PMC4508379/) and [tissue-remodelling review](https://pubmed.ncbi.nlm.nih.gov/18644225/) provide the broader GHK background.

## Melanotan II

The [pilot pigmentation study](https://pubmed.ncbi.nlm.nih.gov/8637402/) and [erectile-function crossover study](https://pubmed.ncbi.nlm.nih.gov/9679884/) are early human investigations. The [food-motivation experiment](https://pubmed.ncbi.nlm.nih.gov/36155088/) used direct brain delivery in male mice. The clinical reports concern [oral pigmentation](https://pubmed.ncbi.nlm.nih.gov/41752902/) and [renal infarction](https://pubmed.ncbi.nlm.nih.gov/31953620/). The [historical review](https://pubmed.ncbi.nlm.nih.gov/16412534/) follows the compound family, and the [social-media analysis](https://pubmed.ncbi.nlm.nih.gov/38808957/) examines public presentation.

## GLOW ingredients

The [review of approved and unapproved peptide therapies](https://pubmed.ncbi.nlm.nih.gov/41966639/) discusses the constituents within a wider safety problem. The [BPC-157 review](https://pubmed.ncbi.nlm.nih.gov/40789979/) assesses the limited human work; the [blood-vessel study](https://pubmed.ncbi.nlm.nih.gov/27847966/) concerns cell and animal models. Together, these papers make a case for investigating a combination carefully. They contain no controlled human result for GLOW itself.

## References

[1] Bonchev A. Changes in Oral Mucosa Associated with Melanotan II Injections: A Case Report. Life (Basel). 2026;16(2):265. https://pubmed.ncbi.nlm.nih.gov/41752902/
[2] Eliason NL, Martin L, Low MJ, Sharpe AL. Melanocortin receptor agonist melanotan-II microinjected in the nucleus accumbens decreases appetitive and consumptive responding for food. Neuropeptides. 2022;96:102289. https://pubmed.ncbi.nlm.nih.gov/36155088/
[3] Peters B, Hadimeri H, Wahlberg R, Afghahi H. Melanotan II: a possible cause of renal infarction: review of the literature and case report. CEN Case Rep. 2020;9(2):159-161. https://pubmed.ncbi.nlm.nih.gov/31953620/
[4] Hadley ME, Dorr RT. Melanocortin peptide therapeutics: historical milestones, clinical studies and commercialization. Peptides. 2006;27(4):921-930. https://pubmed.ncbi.nlm.nih.gov/16412534/
[5] Wessells H, Fuciarelli K, Hansen J, Hadley ME, Hruby VJ, Dorr R, Levine N. Synthetic melanotropic peptide initiates erections in men with psychogenic erectile dysfunction: double-blind, placebo controlled crossover study. J Urol. 1998;160(2):389-393. https://pubmed.ncbi.nlm.nih.gov/9679884/
[6] Dorr RT, Lines R, Levine N, Brooks C, Xiang L, Hruby VJ, Hadley ME. Evaluation of melanotan-II, a superpotent cyclic melanotropic peptide in a pilot phase-I clinical study. Life Sci. 1996;58(20):1777-1784. https://pubmed.ncbi.nlm.nih.gov/8637402/
[7] Healy E, et al. The 'Barbie Drug'-marketing and perceptions of melanotan on social media. J Eur Acad Dermatol Venereol. 2025;39(2):e106-e107. https://pubmed.ncbi.nlm.nih.gov/38808957/
[8] Mortazavi SM, Mohammadi Vadoud SA, Moghimi HR. Topically applied GHK as an anti-wrinkle peptide: Advantages, problems and prospective. BioImpacts. 2025;15:30071. https://pmc.ncbi.nlm.nih.gov/articles/PMC11830136/
[9] Pickart L, Margolina A. Regenerative and Protective Actions of the GHK-Cu Peptide in the Light of the New Gene Data. International Journal of Molecular Sciences. 2018;19(7):1987. https://pmc.ncbi.nlm.nih.gov/articles/PMC6073405/
[10] Lee WJ, Sim HB, Jang YH, Lee SJ, Kim DW, Yim SH. Efficacy of a Complex of 5-Aminolevulinic Acid and Glycyl-Histidyl-Lysine Peptide on Hair Growth. Annals of Dermatology. 2016;28(4):438-443. https://pmc.ncbi.nlm.nih.gov/articles/PMC4969472/
[11] Pickart L, Vasquez-Soltero JM, Margolina A. GHK Peptide as a Natural Modulator of Multiple Cellular Pathways in Skin Regeneration. BioMed Research International. 2015;2015:648108. https://pmc.ncbi.nlm.nih.gov/articles/PMC4508379/
[12] Hostynek JJ, Dreher F, Maibach HI. Human skin penetration of a copper tripeptide in vitro as a function of skin layer. Inflammation Research. 2011;60(1):79-86. https://pmc.ncbi.nlm.nih.gov/articles/PMC3016279/
[13] Mendias CL, Awan TM. Safety and Efficacy of Approved and Unapproved Peptide Therapies for Musculoskeletal Injuries and Athletic Performance. Sports Medicine. 2026. https://pubmed.ncbi.nlm.nih.gov/41966639/
[14] McGuire FP, Martinez R, Lenz A, Skinner L, Cushman DM. Regeneration or Risk? A Narrative Review of BPC-157 for Musculoskeletal Healing. Current Reviews in Musculoskeletal Medicine. 2025. https://pubmed.ncbi.nlm.nih.gov/40789979/
[15] Hsieh MJ, et al. Therapeutic potential of pro-angiogenic BPC157 is associated with VEGFR2 activation and up-regulation. Journal of Molecular Medicine (Berlin). 2017;95:323-333. https://pubmed.ncbi.nlm.nih.gov/27847966/
[16] Pickart L. The human tri-peptide GHK and tissue remodeling. Journal of Biomaterials Science, Polymer Edition. 2008;19(8):969-988. https://pubmed.ncbi.nlm.nih.gov/18644225/

---

An independent audit of skin-and-aesthetic peptide evidence—outcomes, comparators and follow-up, never a medspa protocol or medical recommendation.